Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 23751-23800 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06471673
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
PHASE1/PHASE2Recruiting
18 participants
Started: May 29, 2024 · Completed: Oct 30, 2025
6 conditions1 sponsor1 location
NCT06428188
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
PHASE1/PHASE2Recruiting
60 participants
Started: May 29, 2024 · Completed: Dec 28, 2026
4 conditions1 sponsor1 location
NCT06412666
A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
PHASE2/PHASE3Recruiting
40 participants
Started: May 29, 2024 · Completed: Jan 31, 2030
2 conditions1 sponsor38 locations
NCT06318897
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
PHASE2Recruiting
28 participants
Started: May 29, 2024 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT06266390
Individualized (fMRI-guided) TMS Treatment for Depression
NARecruiting
50 participants
Started: May 29, 2024 · Completed: Apr 30, 2026
3 conditions3 sponsors1 location
NCT06538961
Immune Registry for BK in Kidney Transplant Recipients
N/ARecruiting
60 participants
Started: May 29, 2024 · Completed: May 31, 2026
2 conditions2 sponsors1 location
NCT06361641
Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes
NARecruiting
70 participants
Started: May 29, 2024 · Completed: Oct 19, 2027
4 conditions1 sponsor3 locations
NCT05266846
Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK
PHASE2Recruiting
78 participants
Started: May 29, 2024 · Completed: Feb 16, 2027
3 conditions1 sponsor1 location
NCT06366789
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated Relapsed or Refractory Acute Myeloid Leukemia
PHASE1Recruiting
60 participants
Started: May 29, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06355791
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device
NARecruiting
150 participants
Started: May 29, 2024 · Completed: Dec 31, 2030
3 conditions1 sponsor6 locations
NCT06805045
Image-Guided Surgery In The Treatment Of Rectal Cancer (AR_CRC)
NARecruiting
50 participants
Started: May 29, 2024 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06263491
Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients
PHASE2Recruiting
50 participants
Started: May 29, 2024 · Completed: Mar 1, 2027
1 condition1 sponsor1 location
NCT06360354
A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
PHASE1Recruiting
350 participants
Started: May 29, 2024 · Completed: Feb 25, 2029
1 condition1 sponsor77 locations
NCT06867315
The Safety and Effectiveness of Steep Pulse Therapy System for the Ablation of Benign Prostatic Hyperplasia
NARecruiting
10 participants
Started: May 29, 2024 · Completed: May 29, 2026
1 condition5 sponsors1 location
NCT06167655
A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM
NARecruiting
250 participants
Started: May 29, 2024 · Completed: Aug 30, 2026
1 condition1 sponsor20 locations
NCT06296394
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
N/ARecruiting
146 participants
Started: May 29, 2024 · Completed: Feb 1, 2031
2 conditions3 sponsors18 locations
NCT06427239
Exploratory Clinical Study of HRS-4642 Combined With Adebelimab in the Treatment of Advanced Pancreatic Cancer
PHASE1/PHASE2Recruiting
35 participants
Started: May 29, 2024 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT06474234
Modulation of Gut Microbiota by Probiotic in Children
PHASE2Recruiting
120 participants
Started: May 29, 2024 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT06283797
Efficacy of Automated Insulin Therapy Early Initiated After Diagnosis on Blood Glucose Control in Children and Adolescents With Type 1 Diabetes
NARecruiting
112 participants
Started: May 29, 2024 · Completed: Jun 29, 2027
1 condition5 sponsors4 locations
NCT06450483
Compare the Effects of Different AVNS Parameters on Neck Pain, HRV, Balance in Collegiate Atheletes
NARecruiting
70 participants
Started: May 29, 2024 · Completed: Jul 8, 2024
3 conditions1 sponsor1 location
NCT06445088
Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma
N/ARecruiting
908 participants
Started: May 29, 2024 · Completed: Dec 31, 2026
1 condition5 sponsors5 locations
NCT06419634
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
PHASE1Recruiting
105 participants
Started: May 29, 2024 · Completed: Sep 16, 2030
2 conditions1 sponsor15 locations
NCT06256354
Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival
NARecruiting
3,992 participants
Started: May 29, 2024 · Completed: Jun 30, 2032
4 conditions2 sponsors34 locations
NCT06616363
Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Nat hx With Its Numerous Co-morbidities?
N/ARecruiting
120 participants
Started: May 29, 2024 · Completed: Jul 31, 2028
1 condition2 sponsors1 location
NCT06281665
Treatment With Aspirin After Preeclampsia: TAP Trial
PHASE4Recruiting
60 participants
Started: May 29, 2024 · Completed: Jun 1, 2027
11 conditions2 sponsors1 location
NCT06445842
Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women
NARecruiting
46 participants
Started: May 29, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06382350
Glycemic Excursions in Patients With Type 1 Diabetes Mellitus Using Closed-loop Systems
N/ARecruiting
120 participants
Started: May 29, 2024 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT06480656
Eccentric Cycling Exercise During Pulmonary Rehabilitation Pulmonary Vascular Disease
NARecruiting
22 participants
Started: May 29, 2024 · Completed: Jul 1, 2026
1 condition1 sponsor2 locations
NCT06211257
Superiority Trial Evaluating Digitalized Information Media for Patients with Advanced Sarcomas Receiving Second Line Treatment.
NARecruiting
377 participants
Started: May 29, 2024 · Completed: Mar 31, 2028
2 conditions2 sponsors10 locations
NCT06504368
Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors
PHASE1Recruiting
32 participants
Started: May 29, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06259435
Modulating Energy Density in Time-Restricted Eating
NARecruiting
40 participants
Started: May 29, 2024 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT06470594
Superficial and Deep Endometriosis: Role of Systemic Inflammation as a Marker of Clinical, Surgical, and Reproductive Outcomes
N/ARecruiting
138 participants
Started: May 29, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06131775
Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer
NARecruiting
300 participants
Started: May 29, 2024 · Completed: May 1, 2028
1 condition1 sponsor4 locations
NCT06469372
Cardiac Amyloidosis Discovery Trial
NARecruiting
100 participants
Started: May 28, 2024 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT06564402
Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety
NARecruiting
40 participants
Started: May 28, 2024 · Completed: Jul 1, 2025
2 conditions1 sponsor1 location
NCT06548867
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib
N/ARecruiting
80 participants
Started: May 28, 2024 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT06379698
Rein 3D PRINT PERSONALIZE
NARecruiting
39 participants
Started: May 28, 2024 · Completed: Jun 15, 2027
1 condition1 sponsor1 location
NCT06347471
The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy
PHASE4Recruiting
120 participants
Started: May 28, 2024 · Completed: Apr 30, 2026
1 condition3 sponsors2 locations
NCT06932042
PLADO for Conservative Management of CKD
NARecruiting
48 participants
Started: May 28, 2024 · Completed: Jun 30, 2026
2 conditions3 sponsors1 location
NCT07004569
Angiolite Registry Study
N/ARecruiting
55 participants
Started: May 28, 2024 · Completed: Jul 28, 2025
1 condition1 sponsor1 location
NCT06800911
Metacognitive Beliefs in Obese Patients
N/ARecruiting
90 participants
Started: May 28, 2024 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06332430
Intratumoral CAN2109 in Subjects With Solid Tumors
PHASE1Recruiting
27 participants
Started: May 28, 2024 · Completed: May 30, 2026
2 conditions1 sponsor1 location
NCT06454734
Shock Wave Therapy for Lower Limb Lymphedema
NARecruiting
30 participants
Started: May 28, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06022458
Prenatal Sonographic Prediction of Placental Histology and Function
N/ARecruiting
320 participants
Started: May 28, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06282965
Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury
PHASE1/PHASE2Recruiting
90 participants
Started: May 28, 2024 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT06449430
Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic Version
NARecruiting
270 participants
Started: May 28, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06271239
Effect of Multicomponent Exercises VIVIFRAIL® in Older Adults
NARecruiting
50 participants
Started: May 28, 2024 · Completed: May 30, 2025
3 conditions2 sponsors4 locations
NCT06273436
Healing, Equity, Advocacy and Respect for Mamas
NARecruiting
2,894 participants
Started: May 28, 2024 · Completed: Nov 30, 2028
1 condition2 sponsors1 location
NCT06388954
Plasticity Biomarkers,Interleukin-6 and Motor Performance in Response to Vagus Nerve Stimulation After Stroke
NARecruiting
80 participants
Started: May 28, 2024 · Completed: May 18, 2025
2 conditions1 sponsor1 location
NCT06100263
Breast Cancer Resiliency Through Exercise Program (B-REP)
NARecruiting
200 participants
Started: May 28, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location